Trelegy Ellipta

Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a prescription medication used to treat COPD, asthma. A once-daily inhaler combining three medicines to treat COPD and asthma and improve breathing.

Pairs an inhaled steroid with two long-acting bronchodilators to reduce airway inflammation and keep airways open.

Commonly reported side effects of Trelegy Ellipta include Thrush, Respiratory infections, Headache, Cough, and Hoarseness. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Trelegy Ellipta does not carry an FDA Boxed Warning, but every prescription medicine has risks and possible interactions. Always follow your doctor's instructions and read the medication guide that comes with it.

The active ingredient in Trelegy Ellipta is fluticasone/umeclidinium/vilanterol, which belongs to a class of medicines known as Inhaled Corticosteroid + LAMA + LABA.

Trelegy Ellipta is manufactured by GSK. It was first approved in 2017.

You may be able to lower the cost of Trelegy Ellipta by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.